Novartis Ag Earnings

Novartis Ag’s revenue fell -1.64% since last year same period to $13334.99Mn in the Q4 2025. On a quarterly growth basis, Novartis Ag has generated -7.13% fall in its revenue since last 3-months.

Novartis Ag’s net profit fell -14.52% since last year same period to $2408.82Mn in the Q4 2025. On a quarterly growth basis, Novartis Ag has generated -38.68% fall in its net profits since last 3-months.

Novartis Ag’s net profit margin fell -13.09% since last year same period to 18.06% in the Q4 2025. On a quarterly growth basis, Novartis Ag has generated -33.97% fall in its net profit margins since last 3-months.

Novartis Ag’s earning per share (EPS) estimates for the current quarter stand at 1.99 - a -0.5% fall from last quarter’s estimates.

Novartis Ag’s earning per share (EPS) estimates for the current year stand at 1.99.

Novartis Ag’s earning per share (EPS) jumped 2.53% since last year same period to 2.03 in the Q4 2025. This indicates that the Novartis Ag has generated 2.53% annual rate of jump in its earning per share (EPS) in the last 4 quarters.